It closes a gap, or does nothing. In ageing men with low or low-normal testosterone, 200 mg for one to three months moves levels back into the normal range for most and eases the low-drive, irritable, vaguely-tired feeling that tracks it 1 2. Active seniors, women included, get the same hormone lift plus a bump in grip strength 3. The pooled trials are large on average and almost entirely driven by men who started low 4.
The mood case is the cleanest one. Four weeks eased tension, anger, and the foggy-confused feeling on a standard scale 5. Energy follows the same arc from about week two 1. For erections it only helps men who had a real problem to start 6. None of it is dramatic; it's a gentle restoration, not replacement-grade hormones.
The bottle you buy matters as much as the dose.
What to expect, and when.
- Two weeks: mood steadier, less afternoon flatness, if you had a gap to begin with.
- One to three months: testosterone back toward normal on a blood test; drive and energy follow it.
- Higher doses (400 mg/day, split morning and lunch) are the ceiling of solid clinical use, with no clear sign they beat 200.
The fine print — when to skip it, and what people get wrong
It is not a steroid, a SARM, or a libido pill, and "natural" is not a synonym for clean. Healthy men under forty chasing an edge mostly waste their money 7; more sleep and less stress do more, for free.
Skip it in pregnancy and breastfeeding, and with hormone-sensitive cancers, testosterone therapy, or aromatase inhibitors without a doctor's sign-off. Existing liver disease is a reason to avoid it too 8.
The two documented failures are contamination: about one in four Malaysian products over the mercury limit 9, and adulteration with sildenafil, which fakes a libido lift that vanishes when the bottle runs out 10.
- 1Chinnappan SM, George A, Pandey P, Narke G, Choudhary YK (2021). Effect of Eurycoma longifolia standardised aqueous root extract (Physta) on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study. Food & Nutrition Research. link
- 2Tambi MI, Imran MK, Henkel RR (2012). Standardised water-soluble extract of Eurycoma longifolia, Tongkat ali, as testosterone booster for managing men with late-onset hypogonadism? Andrologia. link
- 3Henkel RR, Wang R, Bassett SH, Chen T, Liu N, Zhu Y, Tambi MI (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors—a pilot study. Phytotherapy Research. link
- 4Leisegang K, Finelli R, Sikka SC, Panner Selvam MK (2022). Eurycoma longifolia (Jack) Improves Serum Total Testosterone in Men: A Systematic Review and Meta-Analysis of Clinical Trials. Medicina (Kaunas). link
- 5Talbott SM, Talbott JA, George A, Pugh M (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition. link
- 6Kotirum S, Ismail SB, Chaiyakunapruk N (2015). Efficacy of Tongkat Ali (Eurycoma longifolia) on erectile function improvement: systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. link
- 7Antonio J, Evans C, Pereira F, Thakkar H, Miriyala V, Rocanelli R, Castillo C, Andal A, Rojas J, Santana JC, Jiannine L, Tartar J, Curtis J (2024). The Effect of Tongkat Ali Supplementation on Body Composition in Exercise-Trained Males and Females. Applied Sciences. link
- 8LiverTox (2024). Tongkat Ali. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. link
- 9Ang HH, Lee KL (2006). Contamination of mercury in Tongkat Ali hitam herbal preparations. Food and Chemical Toxicology. link
- 10Operation Supplement Safety (2023). Tongkat ali: Uses and safety in dietary supplements. link
დაკავშირებული სახელმძღვანელოში (4)
- — Tongkat ali is the other modest hormone nudge in this lane: small effects, mostly in men whose levels already slipped.
- — Tongkat ali only modestly restores already-low testosterone — proper testing tells you whether you need it or something stronger.
- — Tongkat ali sits beside ashwagandha as an adaptogen — both lower cortisol modestly and matter most when you're already stressed.
- — Tongkat ali sourcing is the real risk; a third-party-tested bottle keeps heavy metals and hidden drugs out.
Tongkat Ali (Eurycoma longifolia)
One capsule in the morning with food. Single sourcing decision up front (third-party-tested extract); thereafter trivial.
$20–50/month for a clinically-supported standardised extract; ~$240–600/year. Sits squarely in the $50–$500/year band. Cheaper unstandardised root powder is widely available but is the same product class implicated in heavy-metal contamination surveys (Ang 2006).
Clear functional improvement on validated symptom scales within weeks: AMS (Tambi 2012, Chinnappan 2021), Fatigue Severity Scale from week 2 (Chinnappan 2021), SF-12 mental and vitality components (George 2018). The signal lives in hypogonadal/stressed populations and is absent in healthy eugonadal users (Antonio 2024).
Fatigue Severity Scale fell significantly from week 2 in 200 mg Physta arm (Chinnappan 2021); POMS vigour improved in Japanese trial; subjective energy and reduced afternoon fatigue are the most consistent reader-reported effects. Effect concentrated in low-testosterone or stress-suppressed populations; null in healthy trained adults (Antonio 2024).
Strongest non-hormonal signal. POMS tension −11%, anger −12%, confusion −15% at 200 mg/day x 4 weeks in moderately-stressed adults (Talbott 2013). SF-12 emotional wellbeing +23%, mental component +24.6% at 24 weeks with Physta+multivitamin (George 2018). AMS psychological subscale improved (Chinnappan 2021, Tambi 2012). Null in unstressed healthy adults (Antonio 2024).
Meta-analytic signal on total testosterone with SMD 1.352 (Leisegang 2022), positive RCTs on cortisol and mood (Talbott 2013, George 2018, Chinnappan 2021), and mechanism work in Leydig cells (Low 2013) — but small sample sizes (5 RCTs n=232 in main MA), strong proprietary-extract dominance (7/9 trials used Physta), industry funding common, and one clean negative independent trial in healthy adults (Antonio 2024). Worth trying with monitored sourcing; not Cochrane-tier.
No direct topical or short-term cosmetic effect. Modest, slow indirect contribution via testosterone restoration and lowered cortisol in deficient populations — lean-mass and skin secondary to hormone normalisation in older men (Henkel 2014 muscle-force signal). Speculative outside the hypogonadal subgroup.
POMS confusion subscale fell 15% in stressed adults (Talbott 2013); no direct cognitive-battery improvements demonstrated, and vigilant attention unchanged in trained adults (Antonio 2024). Likely a downstream effect of cortisol/mood normalisation rather than a primary nootropic action.
No direct human PSG or PSQI improvement demonstrated (Antonio 2024 null on PSQI). Murine work shows wakefulness consolidation rather than sedation. Plausible indirect benefit via cortisol reduction in stressed users; high doses or evening dosing reportedly worsen sleep onset.